Rhythm
RHY.AXRhythm Biosciences Limited Price (RHY.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
228,296,917
(3.0492)%Revenue and Profitability
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1,027,617 | 100,000 | 1,108,507 | 2,427,406 | 3,095,842 | 1,690,144 |
| Net Income | -72,127 | -1,753,480 | -1,377,475 | -4,130,780 | -7,721,051 | -6,316,185 | -8,217,557 | -6,856,761 |
| FCF USD | -13 | -1,962,060 | -3,051,858 | -2,788,133 | -5,470,757 | -6,241,711 | -7,056,732 | -6,219,452 |
| OCF USD | -13 | -1,651,299 | -2,941,596 | -2,742,598 | -5,402,486 | -6,214,705 | -6,957,610 | -6,137,171 |
Financial Health - DEBT
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 |
| D/E | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.01 | 0.19 |
| CA/CL | 11.85 | 53.39 | 15.03 | 2.52 | 1.86 | 8.33 | 4.03 | 1.58 |
| TA/TL | 12.25 | 57.33 | 16.41 | 3.30 | 2.25 | 7.92 | 4.23 | 2.33 |
| Total Debt | 0 | 0 | 0 | 42,437 | 0 | 170,140 | 84,606 | 163,822 |
Management Performance
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 51.55% | -21.02% | -34.32% | -217.68% | -447.18% | -106.41% | -186.57% | -519.78% |
| ROE | -5.07% | -21.12% | -23.55% | -224.13% | -452.37% | -85.68% | -139.89% | -790.71% |
| ROA | 0.00% | -20.75% | -40.87% | -152.05% | -215.40% | -74.86% | -106.79% | -451.49% |
| NM % | - | - | -134.05% | -4,130.78% | -696.53% | -260.20% | -265.44% | -405.69% |
| FCF / R% | 0.00% | 0.00% | -296.98% | -2,788.13% | -493.52% | -257.14% | -227.94% | -367.98% |
| FCF / NI% | 0.02% | 111.90% | 119.86% | 69.31% | 82.74% | 98.82% | 85.87% | 90.71% |
| Operating Margin (OM) | - | - | -4.25 | -83.88 | -13.36 | -9.72 | -10.28 | -22.88 |
Per Share
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.00 | -0.02 | -0.01 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 |
| SPS | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| OCPS | 0.00 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
| FCPS | 0.00 | -0.02 | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
| BVPS | 0.01 | 0.09 | 0.05 | 0.02 | 0.01 | 0.03 | 0.03 | 0.00 |
Per Share - CAGR
| Year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.00 | -0.02 | -0.01 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 |
| CAGR-SPS | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| CAGR-OCPS | 0.00 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
| CAGR-FCPS | 0.00 | -0.02 | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 | -0.03 |
| CAGR-BVPS | 0.01 | 0.09 | 0.05 | 0.02 | 0.01 | 0.03 | 0.03 | 0.00 |